Randomized Trialhigh evidence

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation.

The New England journal of medicine·June 4, 2026·PMID 41910347

Why it matters

This trial provides evidence that LAAC is a reasonable alternative to NOACs for stroke prevention in AF patients who are candidates for anticoagulation, offering similar efficacy with significantly less long-term bleeding.

Infographic summary of Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled